Alchemab receives funding boost for Parkinson’s research by John Pinching | Jun 6, 2024 | News | 0 Innovative antibody discovery could lead to new Parkinson’s treatments Read More
Alchemab Therapeutics reveals Alzheimer’s candidate by John Pinching | Jun 22, 2023 | News | 0 ATLX-1088 is regarded as a possible first-in-class human antibody targeting CD33 – a cell surface protein Read More
Alchemab to collaborate with AstraZeneca on prostate cancer research by Lucy Parsons | May 6, 2021 | News | 0 Collaboration will aim to improve understanding of prostate cancer and identify novel antibodies for the disease Read More